ImStem won $1.1 million stem cell research grant from State of Connecticut
ImStem Biotechnology’s Drs. Xiaofang Wang and Ren-He Xu were awarded $1.1 million in state stem cell funding.
News Center
First US Patient Dosed With Investigational Stem Cell Therapy IMS001 for MS
11/23 . 2021
The first US patient has been dosed with an investigational stem cell therapy called IMS001, for multiple sclerosis (MS), developed by ImStem Biotechnology.
-
06 2013.10
-
23 2013.08
The State's Connecticut Innovations Commits $150,000 to ImStem Biotechnology of Farmington
“ImStem's work is not only important from a public health standpoint, but is part of a wider growing biotech industry that is creating well-paying, high-tech jobs,” said Mike Demicco (D-Farmington).